Competitors
| Companies | Market Cap | G | R | O | W | T | H |
|---|---|---|---|---|---|---|---|
|
AstraZeneca PLC LSE:AZN |
232,00 B | 8,90% | 5/6 | 11,21% | -31,13% | 11,75% | UP |
|
GSK LSE:GSK |
83,77 B | 1,19% | 2/6 | 4,12% | -21,35% | -8,40% | UP |
|
Haleon LSE:HLN |
32,93 B | 2,76% | 0/0 | 6,26% | -2,21% | 20,60% | DOWN |
|
Verona Pharma NasdaqGM:VRNA |
9,22 B | 0,00% | 1/4 | 872,82% | -236,11% | -100,00% | UP |
|
Dechra Pharmaceuticals LSE:DPH |
4,40 B | 7,89% | 2/6 | 21,61% | 4,95% | -100,00% | UP |
|
Hikma Pharmaceuticals PLC LSE:HIK |
2,78 B | 0,95% | 4/6 | 2,16% | 28,88% | 46,97% | DOWN |
|
Clinigen AIM:CLIN |
1,23 B | 0,00% | 0,00% | 0,00% | 0,00% | UP | |
|
Vectura Group LSE:VEC |
1,01 B | 0,00% | 2/3 | 0,00% | 0,00% | -100,00% | UP |
|
Myovant Sciences NYSE:MYOV |
1,22 B | 0,00% | 0/1 | 0,00% | 0,00% | 0,15% | UP |
|
ADVANZ PHARMA Corp. TSX:ADVZ |
0,83 B | 0,00% | 0,00% | 0,00% | 0,00% | DOWN | |
|
Alliance Pharma AIM:APH |
0,36 B | 0,62% | 3/6 | 16,78% | 5,28% | -100,00% | UP |
|
Acacia Pharma Group ENXTBR:ACPH |
0,13 B | 0,00% | 0/0 | 0,00% | 0,00% | 0,00% | DOWN |
|
Shield Therapeutics AIM:STX |
0,09 B | 72,34% | 3/6 | -57,18% | 78,49% | 87,50% | UP |
|
Venture Life Group AIM:VLG |
0,08 B | 12,61% | 5/6 | -14,15% | -56,34% | 56,25% | UP |
|
Science in Sport AIM:SIS |
0,08 B | 9,46% | 4/6 | 0,00% | 0,00% | -100,00% | UP |
|
ECO Animal Health Group AIM:EAH |
0,06 B | -4,93% | 0/6 | 5,08% | 27,90% | 85,23% | UP |
|
Poolbeg Pharma PLC AIM:POLB |
0,03 B | 0,00% | 1/1 | 0,00% | 0,00% | 375,00% | DOWN |
|
Sareum Holdings AIM:SAR |
0,02 B | 0,00% | 2/5 | 0,00% | 0,00% | 162,50% | DOWN |
|
Provexis AIM:PXS |
0,01 B | 0,00% | 0/2 | 0,00% | 0,00% | -100,00% | UP |
|
Astrid Intelligence Plc OFEX:ASTR |
0,01 B | 0,00% | 0/0 | 0,00% | 0,00% | 0,00% | DOWN |
